97th General Assembly, 1st Regular Session

HB 593

  
Prohibits a health benefit plan from requiring a higher out-of-pocket cost for an oral anti-cancer medication than for an intravenously-administered cancer medication
Sponsor: Solon, Sheila (031)
Co-Sponsor: Leara, Mike (096) ... et al.
Proposed Effective Date: 8/28/2013
LR Number: 1605H.04P
Last Action: 05/13/2013 - Placed on Informal Calendar
Bill String: HCS HBs 593 & 695
Next House Hearing: Hearing not scheduled
Calendar: Bill currently not on a House calendar

Bill Text

1605H.02I
1605H.04C
1605H.04P

Bill Summary

Bill Summary
HB0593I
Bill Summary
HB0593C
Bill Summary
HB0593P

Fiscal Note

Amendment